Curry Joanna, Coaston Troy, Vadlakonda Amulya, Sakowitz Sara, Mallick Saad, Chervu Nikhil, Khoraminejad Baran, Benharash Peyman
Cardiovascular Outcomes Research Laboratories, Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Surgery, David Geffen School of Medicine at UCLA, University of California Los Angeles, CA, USA.
Surg Open Sci. 2024 Mar 13;18:111-116. doi: 10.1016/j.sopen.2024.03.002. eCollection 2024 Mar.
With the growing opioid epidemic across the US, in-hospital utilization of opioids has garnered increasing attention. Using a national cohort, this study sought to characterize trends, outcomes, and factors associated with in-hospital opioid overdose (OD) following major elective operations.
We identified all adult (≥18 years) hospitalizations entailing select elective procedures in the 2016-2020 National Inpatient Sample. Patients who experienced in-hospital opioid overdose were characterized as (others: ). The primary outcome of interest was in-hospital OD. Multivariable logistic and linear regression models were developed to evaluate the association between in-hospital OD and mortality, length of stay (LOS), hospitalization costs, and non-home discharge.
Of an estimated 11,096,064 hospitalizations meeting study criteria, 5375 (0.05 %) experienced a perioperative OD. Compared to others, were older (66 [57-73] vs 64 [54-72] years, p < 0.001), more commonly female (66.3 vs 56.7 %, p < 0.001), and in the lowest income quartile (26.4 vs 23.2 %, p < 0.001). After adjustment, female sex (Adjusted Odds Ratio [AOR] 1.68, 95 % Confidence Interval [CI] 1.47-1.91, p < 0.001), White race (AOR 1.19, CI 1.01-1.42, p = 0.04), and history of substance use disorder (AOR 2.51, CI 1.87-3.37, p < 0.001) were associated with greater likelihood of OD. Finally, OD was associated with increased LOS (β +1.91 days, CI [1.60-2.21], p < 0.001), hospitalization costs (β +$7500, CI [5900-9100], p < 0.001), and greater odds of non-home discharge (AOR 2.00, CI 1.61-2.48, p < 0.001).
Perioperative OD remains a rare but costly complication after elective surgery. While pain control remains a priority postoperatively, protocols and recovery pathways must be re-examined to ensure patient safety.
随着美国阿片类药物成瘾问题日益严重,阿片类药物在医院的使用情况受到了越来越多的关注。本研究利用全国队列,试图描述大择期手术后院内阿片类药物过量(OD)的趋势、结局及相关因素。
我们在2016 - 2020年全国住院患者样本中确定了所有接受特定择期手术的成年(≥18岁)住院患者。经历院内阿片类药物过量的患者被描述为(其他:)。主要关注的结局是院内OD。建立多变量逻辑回归和线性回归模型,以评估院内OD与死亡率、住院时间(LOS)、住院费用和非回家出院之间的关联。
在估计符合研究标准的11,096,064例住院患者中,5375例(0.05%)经历了围手术期OD。与其他患者相比,(此处原文缺失相关对比内容)年龄更大(66[57 - 73]岁 vs 64[54 - 72]岁,p < 0.001),女性更常见(66.3% vs 56.7%,p < 0.001),且处于最低收入四分位数(26.4% vs 23.2%,p < 0.001)。调整后,女性(调整优势比[AOR]1.68,95%置信区间[CI]1.47 - 1.91,p < 0.001)、白人种族(AOR 1.19,CI 1.01 - 1.42,p = 0.04)和物质使用障碍史(AOR 2.51,CI 1.87 - 3.37,p < 0.001)与OD可能性更大相关。最后,OD与住院时间延长(β +1.91天,CI[1.60 - 2.21],p < 0.001)、住院费用增加(β +7500美元,CI[5900 - 9100],p < 0.001)以及非回家出院几率更高(AOR 2.00,CI 1.61 - 2.48,p < 0.001)相关。
围手术期OD仍然是择期手术后一种罕见但代价高昂的并发症。虽然术后疼痛控制仍然是首要任务,但必须重新审视方案和康复途径以确保患者安全。